| 发明名称 |
Treatment of complement-associated disorders |
| 摘要 |
The present invention concerns a recently discovered macrophage specific receptor, CRIg, and its use in the prevention and treatment of complement-associated disorders, including complement-associated eye conditions, such as age-related macular degeneration (AMD) and choroidal neovascularization (CNV).
|
| 申请公布号 |
US8007798(B2) |
申请公布日期 |
2011.08.30 |
| 申请号 |
US20050249825 |
申请日期 |
2005.10.12 |
| 申请人 |
GENENTECH, INC. |
发明人 |
ASHKENAZI AVI;HELMY KARIM YUSSEF;FONG SHERMAN;GODDARD AUDREY;GURNEY AUSTIN L.;KATSCHKE, JR. KENNETH JAMES;VAN LOOKEREN MENNO;WOOD WILLIAM I. |
| 分类号 |
A61K39/395;C12N15/09;A61K31/711;A61K35/76;A61K38/00;A61K39/39;A61K45/00;A61K48/00;A61P1/04;A61P1/16;A61P1/18;A61P3/10;A61P5/14;A61P7/04;A61P7/06;A61P11/00;A61P11/02;A61P11/06;A61P13/12;A61P17/00;A61P17/04;A61P17/06;A61P19/02;A61P21/00;A61P25/00;A61P25/02;A61P25/28;A61P29/00;A61P31/12;A61P35/00;A61P37/00;A61P37/02;A61P37/06;A61P37/08;C07K14/47;C07K14/705;C07K16/18;C07K16/28;C07K16/42;C12N15/12;C12P21/02;C12P21/08;C12Q1/02;C12Q1/68;G01N33/53;G01N33/574;G01N33/577;G01N33/68 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
